Succinic Acid
| Source | SynBio Database |
|---|---|
| Organization | Myriant + Royal DSM + BioAmber, Inc. |
| Market status | On the market |
| Industry | Food & Agriculture + Health + Industrial |
| Value chain stage | Input |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2C |
| Product categories | Additive + Chemical + Personal Care (Topical) |
| Biotech components | Molecule |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | $155,600,000 USD |
| Country of production | USA |
| Trading symbol | BIOA |
| Trading exchange | NYSE |
| Notes | See documents listed under Succinic Acid; industry & product category are multiple. Product information pertains to BioAmber. BioAmber filed a voluntary petition for Chapter 11 bankruptcy in the U.S. on May 4, 2018 BioAmber liquidated assets in August 2018. |
| Additional link #2 | www.dsm.com/corporate/about/business-entit… |